Ying Du
Chief Executive Officer chez ZAI LAB LIMITED
Fortune : 2 M $ au 31/03/2024
Profil
Fondateur de Zai Lab Ltd, de Hutchison MediPharma Ltd et de Zai Venture Partners, Ying Du est un entrepreneur qui occupe le poste de président-directeur général de Zai Lab Ltd et de partenaire général de Zai Venture Partners (une filiale de Zai Lab Ltd). Le Dr Du est également membre du conseil d'administration d'Eden Biologics, Inc. Dans le passé, le Dr Du a occupé les postes de directeur général de Hutchison MediPharma Ltd, de directeur scientifique de Hutchison China MediTech Ltd, de vice-président exécutif chargé des investissements dans le secteur de la santé chez Hutchison Whampoa (China) Ltd et de partenaire de risque chez Sequoia Capital China Advisors (Hong Kong) Ltd. Ying Du a obtenu un doctorat de l'université de Cincinnati (Ohio) et un diplôme de premier cycle de l'université de Jilin.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ZAI LAB LTD.
0,11% | 03/04/2024 | 1 107 972 ( 0,11% ) | 2 M $ | 31/03/2024 |
Postes actifs de Ying Du
| Sociétés | Poste | Début |
|---|---|---|
| ZAI LAB LIMITED | Chief Executive Officer | 01/04/2014 |
| JHL BIOTECH, INC. | Director/Board Member | 17/12/2012 |
Zai Venture Partners
 Zai Venture Partners Investment ManagersFinance Zai Venture Partner is a venture capital investment firm. The firm is headquartered in Cayman Islands. It is founded by Ying Samantha Du in 2017. | Founder | 01/01/2017 |
Anciens postes connus de Ying Du
| Sociétés | Poste | Fin |
|---|---|---|
Hongshan
 Hongshan Investment ManagersFinance Sequoia Capital China Advisors (Hong Kong) Ltd. (SCCA-HK) is a venture capital investment firm based in Hong Kong. They are a subsidiary of Sequoia Capital Operations LLC, headquartered in Menlo Park, California. The parent firm was founded in 1972 by Donald T. Valentine. The Hong Kong office was established in 2005. Sequoia Capital has additional offices in Shanghai, Beijing, Bangalore, Mumbai and Israel. SCCA-HK caters to both the founders and the management of unlisted firms in their capacity of partner or limited partner. The firm's investors are typically educational and philanthropic institutions. | Private Equity Investor | - |
Hutchison Whampoa (China) Ltd.
 Hutchison Whampoa (China) Ltd. Financial ConglomeratesFinance Part of CK Hutchison Holdings Ltd., Hutchison Whampoa (China) Ltd. is a Chinese company that provides investment services. The private company is based in Hong Kong, Hong Kong. Chi Keung To has been the CEO of the company since 1980. | Corporate Officer/Principal | - |
| HUTCHMED (CHINA) LIMITED | Chief Tech/Sci/R&D Officer | - |
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Chief Executive Officer | - |
Formation de Ying Du
| University of Cincinnati (Ohio) | Doctorate Degree |
| Jilin University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| HUTCHMED (CHINA) LIMITED | Health Technology |
| ZAI LAB LIMITED | Health Technology |
| Entreprise privées | 5 |
|---|---|
Hutchison Whampoa (China) Ltd.
Hutchison Whampoa (China) Ltd. Financial ConglomeratesFinance Part of CK Hutchison Holdings Ltd., Hutchison Whampoa (China) Ltd. is a Chinese company that provides investment services. The private company is based in Hong Kong, Hong Kong. Chi Keung To has been the CEO of the company since 1980. | Finance |
Hongshan
Hongshan Investment ManagersFinance Sequoia Capital China Advisors (Hong Kong) Ltd. (SCCA-HK) is a venture capital investment firm based in Hong Kong. They are a subsidiary of Sequoia Capital Operations LLC, headquartered in Menlo Park, California. The parent firm was founded in 1972 by Donald T. Valentine. The Hong Kong office was established in 2005. Sequoia Capital has additional offices in Shanghai, Beijing, Bangalore, Mumbai and Israel. SCCA-HK caters to both the founders and the management of unlisted firms in their capacity of partner or limited partner. The firm's investors are typically educational and philanthropic institutions. | Finance |
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
Eden Biologics, Inc.
 Eden Biologics, Inc. Pharmaceuticals: MajorHealth Technology Eden Biologics, Inc. is engaged in the manufacture and sale of bio-pharmaceuticals products. It offers cell line cloning, antibody cloning, monoclonal antibody, cell line development, master and working cell banks, cell culture process development, purification process development, formulation development, and analytical assays. The company was founded on June 14, 2012 and is headquartered in Zhupei, Taiwan. | Health Technology |
Zai Venture Partners
Zai Venture Partners Investment ManagersFinance Zai Venture Partner is a venture capital investment firm. The firm is headquartered in Cayman Islands. It is founded by Ying Samantha Du in 2017. | Finance |
